INDOLYLACETIC DERIVATIVES FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
The present invention relates to indolylacetic derivatives of Formula (I) for use in the treatment of neurodegenerative diseases, preferably Amyotrophic Lateral Sclerosis (ALS). The invention further relates to pharmaceutical compositions containing the same, as well as a process for obtaining the indolylacetic derivatives.
Description
FIELD OF THE INVENTION
[0001] The present invention relates to indolylacetic derivatives of Formula (I) for use in the treatment of neurodegenerative diseases, preferably Amyotrophic Lateral Sclerosis (ALS). The invention further relates to pharmaceutical compositions containing the same, as well as a process for obtaining the indolylacetic derivatives.